×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Predictive Genetic Testing and Consumer Wellness Genomics Market Trends

ID: MRFR/LS/9360-HCR
120 Pages
Rahul Gotadki
October 2025

Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, ... read more

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

ReportInfographic
Purchase Options

Market Trends

Key Emerging Trends in the Predictive Genetic Testing and Consumer Wellness Genomics Market

As genetic technology allows people to understand their genes, predictive genetic testing and consumer wellness genomics are growing. These patterns show the increased interest in customized healthcare and genetically-based well-being management. Direct-to-consumer genetic testing is growing, letting people get genetic information without healthcare middlemen. This movement democratizes genetic testing, allowing individuals to query at-home testing kit providers about ancestry, health, and wellbeing. Consumer wellness genomics goes beyond ancestry testing. Companies provide complete genetic insights on health, diet, exercise, and skincare. Demand for holistic genetic information to support individualized lifestyle decisions is rising. Predictive genetic testing is using AI. AI systems evaluate large genomic datasets to provide more precise and thorough genetic interpretations. Health risk forecasts and wellness suggestions are more accurate, improving genetic knowledge. Risk assessment for illness is becoming more important in predictive genetic testing. Consumers are increasingly interested in their genetic predispositions to common and unusual illnesses. Genetic findings informed this proactive illness prevention and early intervention movement. Pharmacogenomics is growing in consumer wellness genomics. Genetic testing helps doctors personalize drugs for maximum effectiveness and minimal negative effects. This trend advances genetically-based individualized therapy. Data security and privacy are becoming more important as genetic data becomes more accessible. The predictive genetic testing sector is taking strong precautions to protect customer genetic information from illegal access and comply with privacy laws. Genetic knowledge is a consumer wellness genomics market focus. Companies are investing in educational activities to better customers' comprehension of genetic information, including how to evaluate findings and make educated choices based on genetic insights. This movement educates people to appropriately manage their genetic data. Consumer genomics firms and healthcare providers are collaborating more. Genetic information should be integrated into healthcare management, as this trend shows. Consumer genomics firms engage with healthcare experts to integrate genetic findings into tailored healthcare regimens. Continuous innovation and research define the predictive genetic testing industry. Scientific advances expand consumer genetic test options. This guarantees customers have access to cutting-edge genetic information as genomics evolves.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

Market Summary

Key Market Trends & Highlights

Market Trends

Predictive Genetic Testing and Consumer Wellness Genomics Market Market Drivers

Market Segment Insights

Regional Insights

Industry Developments

    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

Market Segmentation

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

By Test Type

  • Predictive Testing
  • Consumer Genomics
  • Wellness Genomics

North America

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

By Setting Type

  • Proteomic Testing
  • Metabolic Testing
  • Genomic Testing

Rest of the World

  • Middle East
  • Africa
  • Latin America 

By Application type

  • Breast & Ovarian Cancer
  • Cardiovascular Screening
  • Colon Cancer
  • Others

List of companies covered in this report:

  • 23andMe, Inc. (California)
  • Myriad Genetics, Inc. (US)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (US)
  • Genesis Genetics (US)
  • Agilent Technologies (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Bureau Gravimétrique International (China)
  • Bio-Rad Laboratories Inc. (US)
  • Illumina, Inc. (US)
  • Counsyl, Inc. (California)
  • ARUP Laboratories  (US)
  • Others

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East
  • Africa
  • Latin America 

Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments

  • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
  • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
  • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
  • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
  • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type

  • Wellness Genomics
  • Nutria Genetic
  • Skin & Metabolism Genetics
  • Others
  • Consumer Genomics
  • Predictive Testing
  • Genetic Susceptibility Test
  • Predictive Diagnostic
  • Population Screening

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application

  • Breast & Ovarian Cancer
  • Cardiovascular Screening
  • Diabetic Screening & Monitoring
  • Colon Cancer
  • Parkinsonism/Alzheimer’s Disease
  • Urologic Screening/Prostate Cancer Screening
  • Orthopedic & Musculoskeletal
  • Others

Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type

  • Proteomic Testing
  • Metabolic Testing
  • Genomic Testing

Report Scope

Report Attribute/Metric Details
  Market Size   USD 11.2 Billion
  CAGR   5.4%
  Base Year   2022
  Forecast Period   2023-2032
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Test Type, Application, and Setting Type
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
  Key Vendors   23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US)
  Key Market Opportunities   Rise of application in personalized medicine
  Key Market Drivers   Usage of predictive genetic testing & consumer/wellness genomics in various applications

FAQs

How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

  1. EXECUTIVE SUMMARY
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
      1. Primary Interviews and Information Gathering Process
      2. Breakdown
    5. of Primary Respondents
    6. Forecasting Application
    7. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
    8. Data Triangulation
    9. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Porter’s Five Forces Analysis
    2. Threat of Substitutes
    3. on Supply Chain
  6. Bargaining Power of Suppliers
  7. Bargaining Power of Buyers
  8. Threat of New Entrants
  9. Intensity of Rivalry
    1. Value Chain Analysis
    2. COVID-19 Impact Analysis
      1. Market Impact Analysis
      2. Impact
      3. Regional Impact
      4. Opportunity and Threat Analysis
  10. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE
    2. Overview
    3. Predictive Testing
      1. Genetic
      2. Predictive Diagnostic
      3. Population Screening
    4. Susceptibility Test
    5. Consumer Genomics
    6. Wellness Genomics
      1. Nutria Genetic
      2. Skin & Metabolism Genetics
      3. Others
  11. GLOBAL PREDICTIVE
  12. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
    1. Overview
    2. Breast & Ovarian Cancer
    3. Cardiovascular Screening
    4. Diabetic Screening & Monitoring
    5. Colon Cancer
    6. Parkinsonism/Alzheimer’s
    7. Disease
    8. Urologic Screening/Prostate Cancer Screening
    9. Orthopedic
    10. & Musculoskeletal
    11. Others
  13. GLOBAL PREDICTIVE GENETIC TESTING
  14. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
    1. Overview
    2. Proteomic Testing
    3. Metabolic Testing
    4. Genomic Testing
  15. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
    1. Overview
    2. North America
      1. US
      2. Canada
      3. Germany
      4. France
      5. UK
      6. Italy
      7. Spain
      8. Rest of Europe
    3. Europe
    4. Asia-Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Australia
      6. Rest of Asia-Pacific
    5. Rest of the World
      1. Middle East
      2. Africa
      3. Latin America
  16. COMPANY LANDSCAPE
    1. Overview
    2. Competitive Analysis
    3. Market Share Analysis
    4. Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness
    5. Genomics Market
    6. Competitive Benchmarking
    7. Leading Players in
    8. Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness
    9. Genomics Market
    10. Key developments and Growth Strategies
      1. New
      2. Merger & Acquisitions
    11. Product Launch/Service Deployment
    12. Joint Ventures
    13. Major Players
      1. Sales & Operating Income,
      2. Major Players R&D Expenditure. 2020
  17. COMPANY PROFILES
    1. 23andMe, Inc.
      1. Company Overview
      2. Financial Overview
      3. Products Offered
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    2. Myriad Genetics, Inc.
    3. F.Hoffmann-La
    4. Roche Ltd.
    5. Abbott Laboratories
    6. Genesis Genetics
    7. Agilent Technologies
    8. Thermo Fisher Scientific, Inc.
    9. Bureau
    10. Gravimétrique International
    11. Bio-Rad Laboratories Inc.
    12. Illumina, Inc.
    13. Counsyl, Inc.
    14. ARUP Laboratories
    15. Others
  18. APPENDIX
    1. References
    2. Related Reports
    3. LIST
  19. OF TABLES
  20. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    1. GENOMICS MARKET SYNOPSIS, 2023–2032
  21. GLOBAL PREDICTIVE GENETIC
    1. TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2023–2032
    2. (USD MILLION)
  22. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  23. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  24. GLOBAL
  25. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  26. GLOBAL PREDICTIVE GENETIC TESTING &
  27. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  28. NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  29. MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  30. NORTH AMERICA:
  31. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  32. NORTH AMERICA: PREDICTIVE GENETIC TESTING
  33. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  34. US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE, 2023–2032 (USD MILLION)
  35. US: PREDICTIVE GENETIC
  36. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    1. (USD MILLION)
  37. US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  38. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  39. CANADA:
  40. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
  41. CANADA: PREDICTIVE GENETIC TESTING &
  42. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  43. CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY SETTING TYPE, 2023–2032 (USD MILLION)
  44. EUROPE: PREDICTIVE
  45. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
    1. (USD MILLION)
  46. EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  47. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  48. EUROPE:
  49. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
  50. GERMANY: PREDICTIVE GENETIC TESTING &
  51. CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  52. GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY APPLICATION, 2023–2032 (USD MILLION)
  53. GERMANY: PREDICTIVE GENETIC
  54. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  55. FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  56. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  57. FRANCE:
  58. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  59. FRANCE: PREDICTIVE GENETIC TESTING &
  60. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  61. ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE, 2023–2032 (USD MILLION)
  62. ITALY: PREDICTIVE GENETIC
  63. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    1. (USD MILLION)
  64. ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  65. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  66. SPAIN:
  67. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
  68. SPAIN: PREDICTIVE GENETIC TESTING &
  69. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  70. SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY SETTING TYPE, 2023–2032 (USD MILLION)
  71. UK: PREDICTIVE GENETIC
  72. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    1. MILLION)
  73. UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  74. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  75. UK: PREDICTIVE
  76. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  77. REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  78. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  79. REST
    1. OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
    2. APPLICATION, 2023–2032 (USD MILLION)
  80. REST OF EUROPE: PREDICTIVE
  81. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  82. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  83. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  84. ASIA-PACIFIC:
  85. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  86. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING
  87. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  88. JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY TEST TYPE, 2023–2032 (USD MILLION)
  89. JAPAN: PREDICTIVE GENETIC
  90. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    1. (USD MILLION)
  91. JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  92. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  93. CHINA:
  94. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
  95. CHINA: PREDICTIVE GENETIC TESTING &
  96. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  97. CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY SETTING TYPE, 2023–2032 (USD MILLION)
  98. INDIA: PREDICTIVE GENETIC
  99. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    1. MILLION)
  100. INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  101. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  102. INDIA:
  103. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
  104. AUSTRALIA: PREDICTIVE GENETIC TESTING
  105. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  106. AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  107. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  108. AUSTRALIA: PREDICTIVE
  109. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  110. SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  111. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  112. SOUTH
  113. KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
  114. SOUTH KOREA: PREDICTIVE GENETIC TESTING
  115. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
  116. REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  117. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  118. REST
    1. OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    2. BY APPLICATION, 2023–2032 (USD MILLION)
  119. REST OF ASIA-PACIFIC:
  120. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
  121. REST OF THE WORLD: PREDICTIVE GENETIC
  122. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    1. MILLION)
  123. REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  124. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  125. REST
    1. OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    2. BY SETTING TYPE, 2023–2032 (USD MILLION)
  126. MIDDLE EAST: PREDICTIVE
  127. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
    1. (USD MILLION)
  128. MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  129. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
  130. MIDDLE
  131. EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING
    1. TYPE, 2023–2032 (USD MILLION)
  132. AFRICA: PREDICTIVE GENETIC TESTING
  133. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  134. AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    1. BY APPLICATION, 2023–2032 (USD MILLION)
  135. AFRICA: PREDICTIVE GENETIC
  136. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  137. LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  138. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
  139. LATIN
    1. AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
    2. APPLICATION, 2023–2032 (USD MILLION)
  140. LATIN AMERICA: PREDICTIVE
  141. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    1. (USD MILLION)
  142. LIST OF FIGURES
  143. RESEARCH PROCESS
    1. FIGURE 2
    2. MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  144. GENOMICS MARKET
  145. MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC
  146. TESTING & CONSUMER/WELLNESS GENOMICS MARKET
  147. GLOBAL PREDICTIVE
  148. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020
    1. (%)
  149. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
  150. MARKET SHARE, BY APPLICATION, 2020 (%)
  151. GLOBAL PREDICTIVE GENETIC TESTING
  152. & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%)
    1. FIGURE
  153. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE,
    1. BY REGION, 2020 (%)
  154. NORTH AMERICA: PREDICTIVE GENETIC TESTING &
  155. CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
  156. EUROPE:
  157. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION,
  158. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
  159. GENOMICS MARKET SHARE, BY REGION, 2020 (%)
  160. REST OF THE WORLD: PREDICTIVE
  161. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
  162. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET:
    1. COMPANY SHARE ANALYSIS, 2020 (%)
  163. 23ANDME, INC.: FINANCIAL OVERVIEW
    1. SNAPSHOT
  164. 23ANDME, INC.: SWOT ANALYSIS
  165. MYRIAD GENETICS,
    1. INC.: FINANCIAL OVERVIEW SNAPSHOT
  166. MYRIAD GENETICS INC.: SWOT ANALYSIS
  167. F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
    1. FIGURE 18
    2. F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
  168. ABBOTT LABORATORIES: FINANCIAL
    1. OVERVIEW SNAPSHOT
  169. ABBOTT LABORATORIES: SWOT ANALYSIS
    1. FIGURE
  170. GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
  171. GENESIS GENETICS:
  172. SWOT ANALYSIS
  173. AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
  174. AGILENT TECHNOLOGIES: SWOT ANALYSIS
  175. THERMO FISHER SCIENTIFIC,
    1. INC.: FINANCIAL OVERVIEW SNAPSHOT
  176. THERMO FISHER SCIENTIFIC, INC.:
  177. SWOT ANALYSIS
  178. BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL
    1. OVERVIEW SNAPSHOT
  179. BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT
    1. ANALYSIS
  180. BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT
  181. BIO-RAD LABORATORIES INC..: SWOT ANALYSIS
  182. ILLUMINA, INC.:
    1. FINANCIAL OVERVIEW SNAPSHOT
  183. ILLUMINA, INC.: SWOT ANALYSIS
    1. FIGURE
  184. COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  185. COUNSYL, INC.: SWOT
    1. ANALYSIS
  186. ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
    1. FIGURE
  187. ARUP LABORATORIES: SWOT ANALYSIS

Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions